Author

S. K. Johnston

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 7 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 7 Research Focus:cell type annotation· 5 Assay:imaging· 5 Research Focus:differential expression· 4 Approach:statistical model· 4 Assay:clinical cohort / trial· 3 Approach:experimental assay· 3 Research Focus:clustering· 2

Frequent Co-Authors

K. R. Swanson· 8 shared L. S. Hu· 6 shared A. B. Porter· 5 shared M. M. Mrugala· 5 shared A. Hawkins-Daarud· 4 shared C. R. Rickertsen· 4 shared P. Whitmire· 4 shared S. C. Massey· 4 shared

Activity by Year

2018-2020 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

8 shared papersCancer Biology

K. R. Swanson

Mutual co-authors in cluster

Author profile →

8 papers

Recent·Most cited

Sex Differences in MRI-Based Metrics of Glioma Invasion and Brain Mechanics

B. J. Anderies, S. F. Yee, P. R. Jackson, C. R. Rickertsen, A. J. Hawkins-Daarud, S. K. Johnston, K. R. Clark-Swanson, J. M. Hoxworth, Y. Le, Y. Zhou, K. M. Pepin, S. C. Massey, L. S. Hu, J. R. Huston, K. R. Swanson

This study examines sex differences in MRI and MRE metrics related to glioma invasion and brain mechanics, finding sex-dependent relationships between tumor stiffness and growth parameters.

bioRxiv · Nov 21, 2020 · PreprintBiophysics

Days Gained Response Discriminates Treatment Response in Patients with Recurrent Glioblastoma Receiving Bevacizumab-based Therapies

K. W. Singleton, A. B. Porter, L. S. Hu, S. K. Johnston, K. M. Bond, C. R. Rickertsen, G. De Leon, S. A. Whitmire, K. R. Clark-Swanson, M. M. Mrugala, K. R. Swanson

This study evaluates Days Gained (DG) as a metric for assessing treatment response in recurrent glioblastoma patients receiving bevacizumab-based therapies, showing its prognostic significance for survival outcomes.

bioRxiv · Aug 30, 2019Cancer Biology

Sex differences in seizure at presentation in glioma population

S. Ranjbar, B. J. Anderies, K. W. Singleton, S. K. Johnston, C. R. Rickertsen, A. Sharma, A. B. Porter, M. M. Mrugala, L. S. Hu, J. R. Mitchell, J. B. Rubin, K. R. Swanson

This study examines the association between tumor location and seizure risk in male and female glioma patients.

bioRxiv · Aug 4, 2019 · PreprintCancer Biology

Sex Differences in Predictors of Seizure in Contrast-Enhancing Gliomas at Clinical Presentation: A Network Approach

S. K. Johnston, A. Khurana, P. Whitmire, S. Ranjbar, A. Sharma, A. Hawkins-Daarud, J. B. Rubin, A. B. Porter, P. D. Canoll, K. Egan, L. S. Hu, M. M. Mrugala, P. Kumthekar, K. R. Swanson

The paper uses a machine learning model to predict seizure risk in glioma patients at presentation, finding sex, tumor size, and age as significant predictors.

bioRxiv · Jul 23, 2019 · PreprintCancer Biology

From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response

J. A. Gallaher, S. C. Massey, A. C. Hawkins-Daarud, S. S. Noticewala, R. C. Rockne, S. K. Johnston, L. Gonzalez-Cuyar, J. Juliano, O. Gil, K. R. Swanson, P. Canoll, A. R. A. Anderson

This paper develops a hybrid agent-based model to study how intratumor heterogeneity affects glioblastoma growth and treatment response using multiscale data and mathematical frameworks.

bioRxiv · May 26, 2019Cancer Biology

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

S. C. Massey, H. White, P. Whitmire, T. Doyle, S. K. Johnston, K. W. Singleton, P. R. Jackson, A. Hawkins-Daarud, B. R. Bendok, A. B. Porter, S. Vora, J. N. Sarkaria, M. M. Mrugala, K. R. Swanson

The paper uses image-based metrics to predict TMZ response in GBM patients, finding that less invasive tumors show greater volumetric response and improved survival.

bioRxiv · Jan 2, 2019Cancer Biology

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: a Multi-disciplinary Team-based, Multifactorial Analytical Approach

S. K. Johnston, P. Whitmire, S. C. Massey, P. Kumthekar, A. B. Porter, N. Raghunand, L. F. Gonzalez-Cuyar, M. M. Mrugala, A. Hawkins-Daarud, P. R. Jackson, L. S. Hu, J. N. Sarkaria, L. Wang, R. A. Gatenby, K. M. Egan, , K. R. Swanson

The paper introduces the ENDURES consortium to study extreme survivors of glioblastoma by integrating clinical data and creating patient-specific tumor models.

bioRxiv · Nov 4, 2018 · PreprintCancer Biology

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients

P. Whitmire, C. R. Rickertsen, A. Hawkins-Daarud, E. Carrasco, J. Lorence, G. De Leon, L. Curtin, S. Bayless, K. Clark-Swanson, N. C. Peeri, C. Corpuz, C. P. Lewis-de los Angeles, B. R. Bendok, L. Gonzalez-Cuyar, S. Vora, , K. R. Swanson

This study identifies sex-specific predictors of survival in glioblastoma patients using MR imaging and clinical data.

bioRxiv · Sep 25, 2018Cancer Biology